Published in Eur J Pain on December 16, 2009
Merits of publishing a negative and prematurely ended study on intrathecal methylprednisolone for severe and longstanding complex regional pain syndrome (CRPS-I). Eur J Pain (2010) 1.62
Immunoglobulin responsive chronic pain. J Clin Immunol (2010) 0.80
Management of patients with complex regional pain syndrome type I. Osteoporos Int (2016) 0.76
Migraine--current understanding and treatment. N Engl J Med (2002) 9.80
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Migraine as a risk factor for subclinical brain lesions. JAMA (2004) 5.02
Coding of facial expressions of pain in the laboratory mouse. Nat Methods (2010) 4.47
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron (2004) 3.28
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet (2005) 3.27
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain (2005) 2.59
Structural brain changes in migraine. JAMA (2012) 2.47
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet (2007) 2.35
Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet (2010) 2.35
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet (2012) 2.34
Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol (2006) 2.31
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord (2002) 2.23
Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain (2009) 2.22
Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet (2011) 2.12
Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain (2010) 2.07
Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet (2011) 1.98
Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron (2009) 1.97
Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol (2007) 1.95
Molecular genetics of migraine. Hum Genet (2009) 1.91
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest (2008) 1.81
Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet (2012) 1.64
Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord (2006) 1.57
Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol (2003) 1.51
Anatomical variations in the circle of Willis and migraine susceptibility: is there an association? Headache (2009) 1.51
Migraine is not associated with enhanced atherosclerosis. Cephalalgia (2012) 1.49
Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord (2004) 1.48
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol (2011) 1.45
Development of a symptoms questionnaire for complex regional pain syndrome and potentially related illnesses: the Trauma Related Neuronal Dysfunction Symptoms Inventory. Arch Phys Med Rehabil (2008) 1.44
Importance of nondopaminergic features in evaluating disease severity of Parkinson disease. Neurology (2014) 1.43
Frontal lobe structure and executive function in migraine patients. Neurosci Lett (2008) 1.42
Attack frequency and disease duration as indicators for brain damage in migraine. Headache (2008) 1.37
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord (2009) 1.36
Brain stem and cerebellar hyperintense lesions in migraine. Stroke (2006) 1.34
The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord (2010) 1.34
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci (2010) 1.28
Cutaneous allodynia as a predictor of migraine chronification. Brain (2013) 1.28
Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation (2011) 1.28
High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol (2010) 1.27
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain (2011) 1.22
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain (2010) 1.21
Migraine: gene mutations and functional consequences. Curr Opin Neurol (2007) 1.20
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology (2013) 1.20
Complex regional pain syndrome 1--the Swiss cohort study. BMC Musculoskelet Disord (2008) 1.19
Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. Arch Neurol (2009) 1.18
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord (2010) 1.18
Clinical subtypes of Parkinson's disease. Mov Disord (2010) 1.18
A high-density association screen of 155 ion transport genes for involvement with common migraine. Hum Mol Genet (2008) 1.17
Hyperventilation in head injury: a review. Chest (2005) 1.16
Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol (2002) 1.15
Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol (2003) 1.14
Divergent sodium channel defects in familial hemiplegic migraine. Proc Natl Acad Sci U S A (2008) 1.13
Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what? Curr Opin Neurol (2009) 1.11
DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord (2010) 1.10
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord (2010) 1.09
Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab (2007) 1.08
The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online. Hum Mutat (2007) 1.08
Clinical tests for the evaluation of postural instability in patients with parkinson's disease. Arch Phys Med Rehabil (2003) 1.07
Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci (2011) 1.07
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol (2012) 1.05
Familial and sporadic hemiplegic migraine: diagnosis and treatment. Curr Treat Options Neurol (2013) 1.05
Thinking about movement hurts: the effect of motor imagery on pain and swelling in people with chronic arm pain. Arthritis Rheum (2008) 1.04
Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet (2011) 1.04
Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry (2011) 1.03
Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Hum Genet (2006) 1.02
Development of a severity score for CRPS. Pain (2010) 1.02
Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord (2008) 1.01
Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL. Stroke (2007) 1.00
A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health (2008) 0.99
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Ann Neurol (2002) 0.99
Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice. J Neurosci (2012) 0.98
Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain. Mol Pain (2010) 0.98
Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur J Neurosci (2007) 0.97
Spreading of complex regional pain syndrome: not a random process. J Neural Transm (Vienna) (2011) 0.97
Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Medicine (Baltimore) (2003) 0.96
Gain of function in FHM-1 Cav2.1 knock-in mice is related to the shape of the action potential. J Neurophysiol (2010) 0.95
A comparative study of odor identification and odor discrimination deficits in Parkinson's disease. Mov Disord (2008) 0.95
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages--3rd-6th decades. Radiology (2003) 0.94
The influence of gender on phenotype and disease progression in patients with Huntington's disease. Parkinsonism Relat Disord (2012) 0.94
Epigenetic mechanisms in migraine: a promising avenue? BMC Med (2013) 0.93
TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PLoS One (2013) 0.93
Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol (2009) 0.93
Lenticulostriate arterial lumina are normal in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a high-field in vivo MRI study. Stroke (2010) 0.92
Imaging mass spectrometry to visualize biomolecule distributions in mouse brain tissue following hemispheric cortical spreading depression. J Proteomics (2012) 0.92
Cerebral activation during motor imagery in complex regional pain syndrome type 1 with dystonia. Pain (2007) 0.92
Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurol Sci (2012) 0.92